Biodegradable collagen matrix implant for trabeculectomy

Expert Review of Ophthalmology

Volumn 3, Issue 6, 2008, Pages 613-617

  Zelefsky, Joseph R ^a,d,e   Hsu, Wei Cherng ^b,f   Ritch, Robert ^a,c  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e EAR AND THROAT HOSPITAL   (United States)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Biodegradable collagen; Filtering bleb; Glaucoma; IGen"; Matrix; Microtechnology; OculusGen ; Ologen ; Tissue bioengineering; Trabeculectomy

Indexed keywords

ANTIGLAUCOMA AGENT; COLLAGEN IMPLANT; FLUOROURACIL; MITOMYCIN C;

ARTICLE; BIODEGRADABLE IMPLANT; EXTRACELLULAR MATRIX; FIBROBLAST; INTRAOCULAR PRESSURE; MYOFIBROBLAST; NONHUMAN; OPEN ANGLE GLAUCOMA; SCAR FORMATION; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE FLAP; TRABECULECTOMY;

EID: 70049105105     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/17469899.3.6.613     Document Type: Article

References (22)

1. Arici MK, Demircan S, Topalkara A. Effect of conjunctival structure and inflammatory cell counts on intraocular pressure after trabeculectomy. Ophthalmologica 213, 371-375 (1999).
2. van Buskirk EM. Cysts of Tenon's capsule following filtration surgery. Am. J. Ophthalmol. 94, 522-527 (1982).
3. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv. Ophthalmol. 48, 314-346 (2003).
4. DeBry PW, Perkins TW, Heatley G et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch. Ophthalmol. 120, 297-300 (2002).
5. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch. Ophthalmol. 116, 443-447 (1998).
6. Soltau JB, Rothman R, Budenz DL et al. Risk factors for glaucoma filtering bleb infections. Arch. Ophthalmol. 118, 338-343 (2000).
7. Young MJ, Borràs T, Walte M, Ritch R. Potential applications of tissue engineering to glaucoma. Arch. Ophthalmol. 123, 1725-1731 (2005).
8. Chen HS, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: an animal model. Invest. Ophthalmol. Vis. Sci. 47, 5310-5314 (2006).
9. Hsu WC, Ritch R, Krupin T, Chen HS. Tissue bioengineering for surgical bleb defects: an animal study. Graefes Arch. Clin. Exp. Ophthalmol. 246, 709-717 (2008).
10. Budenz DL, Barton K, Tseng SCG. Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am. J. Ophthalmol. 130, 580-588 (2000).
11. Buxton JN, Lavery KT, Liebmann JM et al. Reconstruction of filtering blebs with free conjunctival autografts. Ophthalmology 101, 635-639 (1994).
12. Schnyder CC, Shaarawy T, Ravinet E et al. Free conjunctival autologous graft for bleb repair and bleb reduction after trabeculectomy and nonpenetrating filtering surgery. J. Glaucoma 11, 10-16 (2002).
13. Wilson MR, Kotas-Neumann R. Free conjunctival patch for repair of persistent late bleb leak. Am. J. Ophthalmol. 117, 569-574 (1994).
14. Burnstein AL, WuDunn D, Knotts SL et al. Conjunctival advancement versus nonincisional treatment for late-onset glaucoma filtering bleb leaks. Ophthalmology 109, 71-75 (2002).
15. Blok MD, Kok JH, van Mil C et al. A use of the Megasoft Bandage Lens for treatment of complications after trabeculectomy. Am. J. Ophthalmol. 110, 264-268 (1990).
16. Fourman S, Wiley L. Use of a collagen shield to treat a glaucoma filter bleb leak. Am. J. Ophthalmol. 107, 673-674 (1989).
17. Chen, Hsu. Initial clinical experience with biodegradable 3D porous collagen-glycosaminoglycan scaffold (OculusGen®) for treatment of refractory glaucoma. Presented at: World Ophthalmology Congress. São Paulo, Brazil, 19-24 February 2006.
18. Ruokonen P, Rieger R, Berndt S, Mai C, Rieck P. First experiences with the OculusGen collagen-matrix-implant in glaucoma surgery. Presented at: World Glaucoma Congress 2007. Singapore, 18-21 July 2007.
19. Kaljurand K. Ologen collagen matrix implant in glaucoma filtering surgery. Presented at: World Glaucoma Congress 2007. Singapore, 18-21 July 2007.
20. Imtiaz Ali S. Study of the safety and effectiveness of Ologen™ collagen matrix implant and MMC in standard glaucoma filtration surgery. Presented at: World Ophthalmology Congress 2008. Hong Kong, 28 June - 2 July 2008.
21. Yuan F. Biodegradable 3D-porous collagen - glycosaminoglycan scaffold for treatment of refractory glaucoma. Presented at: World Ophthalmology Congress 2008. Hong Kong, 28 June - 2 July 2008.
22. Grewal SPS. Adjunctive use of biodegradable porous collage-glycosaminoglycan implant in phacoemulsification combined with trabeculectomy for surgical management of primary open-angle glaucoma. Presented at: World Ophthalmology Congress 2008. Hong Kong, 28 June - 2 July 2008.